Healthcare

With just over one month until the Affordable Care Act’s health-care exchanges roll out, new research from Columbia University shows the complexity of choosing coverage for consumers, as some experts claim the law’s subsidies do not incentivize consumers to pick their health-care wisely. What’s more, consumers picking the wrong plan will cost taxpayers—to the tune of about $9 billion per year.

By Bill Toland, Pittsburgh Post-Gazette There's a learning curve with all online transactions -- banking on the Web, buying songs from iTunes. So how long will it take America to warm up to shopping for health insurance online?And, more importantly, how long will it take us to shop wisely?That depends largely on the architecture of the websites through which America will do its shopping, according to a new paper written by a University of Pennsylvania Law School health insurance expert and several other colleagues.

(Reuters) - Nobody wants their health benefits cut, but a funny thing happens when U.S. consumers shop for plans on their own: They buy less coverage than they had before. That "buying low" behavior observed in data collected by consulting companies like Aon Hewitt and Liazon Corp may soon happen much more often. With the start of Obamacare and corporate open enrollment seasons, millions of Americans are likely to buy their own healthcare coverage on public and private exchanges.

FORTUNE -- We now know that 7.1 million people signed up for health care insurance during the Affordable Care Act (ACA)'s initial enrollment period, which ended on March 31. But, what is less well known is the potential financial disaster facing these millions of consumers who have chosen policies during the last six months.

"We’re very excited about this class," said Vince Ponzo '03, the director of the Eugene Lang Entrepreneurship Center. "These budding entrepreneurs represent the breadth of expertise at Columbia University."

New research from Columbia Business School warns that consumers will make mistakes totaling $9 billion; offers prescriptions to help improve consumer experience using new state healthcare exchanges

Industry practitioners, alumni, students, and staff and faculty members gathered together for the ninth annual Columbia Business School Healthcare Conference on November 30 in New York City.

Surya N. Mohapatra, former chairman and chief executive officer of Quest Diagnostics Incorporated, has been named Executive in Residence at Columbia Business School.

Research reveals role of government funding in pharmaceutical R&D and its direct and indirect impact on innovative new drugs

Sergio Marchionne, CEO of Fiat and Chrysler Group, and Brent James, MD, chief quality officer of Intermountain Healthcare, were honored on Wednesday, November 2, as recipients of Columbia Business School’s second annual Deming Cup awards.